Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist
نویسندگان
چکیده
منابع مشابه
Anaphylactic reaction during haemodialysis on AN69 membrane in a patient receiving angiotensin II receptor antagonist.
Sir, Biju et al. w1x reported the case of an ESRD patient on a treatment with the AT II antagonist losartan who developed breathlessness, agitation, tachycardia, and hypertension after about 1 h of haemodialysis. Since this episode happened 943 Nephrol Dial Transplant (2002) 17: 943
متن کاملFimasartan, a novel angiotensin II receptor antagonist.
Fimasartan (Kanarb®), an angiotensin II receptor antagonist with selectivity for the AT1 receptor subtype, is a pyrimidinone-related heterocyclic compound that was developed by Boryung Pharm. Co., Ltd. Among numerous synthetic derivatives, fimasartan was chosen as a new drug candidate through in vitro and in vivo screening studies. Pharmadynamic-pharmacokinetic properties and safety profiles we...
متن کاملeffect of angiotensin ii type 1 receptor antagonist, losartan on inflammatory factor in atherosclerotic rabbits
materials and methods: 32 new zealand rabbits were randomly divided into three groups: control group, high-cholesterol group and losartan group. the level of weights, serum lipid levels and inflammatory factors, such as il-6 and hs c-reactive protein were detected before the losartan intervention and two months after the losartan intervention respectively. the content of angii was detected on l...
متن کاملIntestinal manifestations with a surface-treated AN69 membrane and ACEI during haemodialysis.
Sir, AN69-associated reactions in haemodialysed patients receiving angiotensin-converting enzyme inhibitors (ACEI) are well-documented [1]. The negatively charged AN69 membrane is thought to activate the bradykinin system. Moreover, ACEI reduces bradykinin inactivation. Surface-treated AN69 is considered to be safer in that regard. To our knowledge, only one case of anaphylactoid reaction induc...
متن کاملAbdominal manifestations associated with use of a surface-treated AN69 membrane and ACEI during haemodialysis.
1. Adler KR, Lempert N, Scharfman WB. Chronic granulocytic leukemia following successful renal transplantation. Cancer 1978; 41: 2206–2208 2. Koca E, Cetiner D, Goker H et al. Complete cytogenetic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation. Clin Nephrol 2005; 64: 324–325 3. Veneri D, Franchini M, Bonora E. Imatinib and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2001
ISSN: 1460-2385,0931-0509
DOI: 10.1093/ndt/16.9.1955